Mark Steven Duxon
Gründer bei Transpharmation Ltd.
Aktive Positionen von Mark Steven Duxon
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Transpharmation Ltd.
 Transpharmation Ltd. BiotechnologyHealth Technology Part of Vivocore, Inc., Transpharmation Ltd. is a contract research organization. The company is based in London, UK. The British company was founded in 2010 by Neil Upton, Mark Steven Duxon. Mark Steven Duxon has been the CEO since 2010. Transpharmation was acquired by Vivocore, Inc. on February 07, 2022. | Direktor/Vorstandsmitglied | 23.01.2012 | - |
| Vorstandsvorsitzender | 17.08.2010 | - | |
| Gründer | 17.08.2010 | - | |
Vivocore, Inc.
 Vivocore, Inc. Miscellaneous Commercial ServicesCommercial Services Vivocore, Inc. is a non-invasive research and Canadian development company. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Mark Steven Duxon
Statistik
International
| Vereinigtes Königreich | 2 |
| Kanada | 2 |
Operativ
| Director/Board Member | 2 |
| Chief Executive Officer | 1 |
| Founder | 1 |
Sektoral
| Health Technology | 2 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Transpharmation Ltd.
Transpharmation Ltd. BiotechnologyHealth Technology Part of Vivocore, Inc., Transpharmation Ltd. is a contract research organization. The company is based in London, UK. The British company was founded in 2010 by Neil Upton, Mark Steven Duxon. Mark Steven Duxon has been the CEO since 2010. Transpharmation was acquired by Vivocore, Inc. on February 07, 2022. | Health Technology |
Vivocore, Inc.
Vivocore, Inc. Miscellaneous Commercial ServicesCommercial Services Vivocore, Inc. is a non-invasive research and Canadian development company. | Commercial Services |
- Börse
- Insiders
- Mark Steven Duxon
- Erfahrung
